Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
The aim of review. A critical estimation of interferon-free modes of antiviral therapy (AVT) of chronic hepatitis C (CHC) according to the analysis of clinical studies.Key points. Interferon-free variants of CHC treatment have certain advantages over modes of interferon-α based treatment. Monotherap...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Gastro LLC
2014-10-01
|
| Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Subjects: | |
| Online Access: | https://www.gastro-j.ru/jour/article/view/1125 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823860091252637696 |
|---|---|
| author | S. N. Batskikh |
| author_facet | S. N. Batskikh |
| author_sort | S. N. Batskikh |
| collection | DOAJ |
| description | The aim of review. A critical estimation of interferon-free modes of antiviral therapy (AVT) of chronic hepatitis C (CHC) according to the analysis of clinical studies.Key points. Interferon-free variants of CHC treatment have certain advantages over modes of interferon-α based treatment. Monotherapy by drugs with direct action on virus is less effective in comparison to combined application. Combination of agents with direct antiviral effect considerably reduces risk of resistance, increasing probability of virus eradication. The role of ribavirin at various interferon-free modes of treatment requires specification.Conclusion. New variants of the AVT providing combined application of agents with direct antiviral action (without interferon and ribavirin), will allow to simplify algorithms principally, decrease terms and improve efficacy of treatment in all categories of patients. Such variants of therapy can be considered as a new paradigm of CHC treatment. |
| format | Article |
| id | doaj-art-eca484ff199e4b728bbebad73b1c9c58 |
| institution | Kabale University |
| issn | 1382-4376 2658-6673 |
| language | Russian |
| publishDate | 2014-10-01 |
| publisher | Gastro LLC |
| record_format | Article |
| series | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| spelling | doaj-art-eca484ff199e4b728bbebad73b1c9c582025-02-10T16:14:39ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732014-10-012442331725Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?S. N. Batskikh0Federal budget institution of science «Central research institute of epidemiology» of the Federal service on customers' rights protection and human well-being surveillanceThe aim of review. A critical estimation of interferon-free modes of antiviral therapy (AVT) of chronic hepatitis C (CHC) according to the analysis of clinical studies.Key points. Interferon-free variants of CHC treatment have certain advantages over modes of interferon-α based treatment. Monotherapy by drugs with direct action on virus is less effective in comparison to combined application. Combination of agents with direct antiviral effect considerably reduces risk of resistance, increasing probability of virus eradication. The role of ribavirin at various interferon-free modes of treatment requires specification.Conclusion. New variants of the AVT providing combined application of agents with direct antiviral action (without interferon and ribavirin), will allow to simplify algorithms principally, decrease terms and improve efficacy of treatment in all categories of patients. Such variants of therapy can be considered as a new paradigm of CHC treatment.https://www.gastro-j.ru/jour/article/view/1125chronic hepatitis cantiviral therapyinterferon αribavirinprotease inhibitorspolymerase inhibitorsresistance |
| spellingShingle | S. N. Batskikh Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? Российский журнал гастроэнтерологии, гепатологии, колопроктологии chronic hepatitis c antiviral therapy interferon α ribavirin protease inhibitors polymerase inhibitors resistance |
| title | Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? |
| title_full | Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? |
| title_fullStr | Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? |
| title_full_unstemmed | Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? |
| title_short | Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm? |
| title_sort | interferon free therapy of chronic hepatitis c replacement of medications or new treatment paradigm |
| topic | chronic hepatitis c antiviral therapy interferon α ribavirin protease inhibitors polymerase inhibitors resistance |
| url | https://www.gastro-j.ru/jour/article/view/1125 |
| work_keys_str_mv | AT snbatskikh interferonfreetherapyofchronichepatitiscreplacementofmedicationsornewtreatmentparadigm |